Class II
Ongoing
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20
This recall is currently active, issued December 18, 2024. It was issued by Mylan Institutional Inc.
- Company
- Mylan Institutional Inc
- Recall Initiated
- November 19, 2024
- Posted
- December 18, 2024
- Recall Number
- D-0136-2025
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 205 cartons
- Firm Location
- Rockford, IL, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Subpotent and Superpotent Drug
Distribution
Nationwide in the USA.
Lot / Code Info
Lot #: 3115869, Exp. Date 03/2025
More recalls by Mylan Institutional Inc
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026